(2E)-2-(naphthylmethylene)hydrazinecarbothioamide | 1262239-10-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: (2E)-2-(naphthylmethylene)hydrazinecarbothioamide
• 英文别名: [(E)-naphthalen-1-ylmethylideneamino]thiourea
• CAS: 1262239-10-0
• 化学式: C₁₂H₁₁N₃S
• 分子量: 229.305
• InChiKey: LPGXRPAESUOQHF-RIYZIHGNSA-N

物化性质

• 熔点：
  205.5-208.8 °C
• 沸点：
  419.4±28.0 °C(predicted)
• 密度：
  1.24±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  82.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2E)-2-(naphthylmethylene)hydrazinecarbothioamide 、 2-溴-3'-硝基苯乙酮 以 乙醇 为溶剂， 生成 1-(naphthalen-1-ylmethylene)-2-(4-(3-nitrophenyl)thiazol-2-yl)hydrazine
  参考文献：
  名称：

  4-（3-硝基苯基）噻唑-2-基hydr衍生物作为抗氧化剂和选择性hMAO-B抑制剂：合成，生物活性和计算分析

  摘要：

  抽象的 设计，合成和评估了一系列新的4-（3-硝基苯基）噻唑-2-基hydr衍生物，以评估它们对人单胺氧化酶（hMAO）A和B同工型的抑制作用。为了建立稳固的结构-活性关系，将不同的（未）取代的（杂）芳族取代基与N的N 1连接。生物试验的结果表明，hydrazothiazole核轴承中的C4存在下，在所述官能化的苯基环的元与硝基位置代表着一个重要的药效特征，以获得选择性和可逆的人MAO-B抑制神经变性疾病的治疗。此外，最有效的和选择性的MAO-B抑制剂进行了评价，在硅片作为潜在的胆碱酯酶（AChE / BuChE）抑制剂，并在体外具有抗氧化活性。从分子建模研究中获得的结果为所报道的MAO抑制特性的多重相互作用和结构要求提供了见识。

  DOI：

  10.1080/14756366.2019.1571272
• 作为产物：
  描述：

  1-萘甲醛 、 氨基硫脲 在 溶剂黄146 作用下， 以 乙醇 为溶剂， 生成 (2E)-2-(naphthylmethylene)hydrazinecarbothioamide
  参考文献：
  名称：

  4-（3-硝基苯基）噻唑-2-基hydr衍生物作为抗氧化剂和选择性hMAO-B抑制剂：合成，生物活性和计算分析

  摘要：

  抽象的 设计，合成和评估了一系列新的4-（3-硝基苯基）噻唑-2-基hydr衍生物，以评估它们对人单胺氧化酶（hMAO）A和B同工型的抑制作用。为了建立稳固的结构-活性关系，将不同的（未）取代的（杂）芳族取代基与N的N 1连接。生物试验的结果表明，hydrazothiazole核轴承中的C4存在下，在所述官能化的苯基环的元与硝基位置代表着一个重要的药效特征，以获得选择性和可逆的人MAO-B抑制神经变性疾病的治疗。此外，最有效的和选择性的MAO-B抑制剂进行了评价，在硅片作为潜在的胆碱酯酶（AChE / BuChE）抑制剂，并在体外具有抗氧化活性。从分子建模研究中获得的结果为所报道的MAO抑制特性的多重相互作用和结构要求提供了见识。

  DOI：

  10.1080/14756366.2019.1571272

文献信息

• New biologically dynamic hybrid pharmacophore triazinoindole-based-thiadiazole as potent α-glucosidase inhibitors: In vitro and in silico study
  作者：Aftab Ahmad Khan、Fazal Rahim、Muhammad Taha、Wajid Rehman、Naveed Iqbal、Abdul Wadood、Nisar Ahmad、Syed Adnan Ali Shah、Mohammed M. Ghoneim、Sultan Alshehri、Mohammed Salahuddin、Khalid Mohammed Khan

  DOI：10.1016/j.ijbiomac.2021.12.147

  日期：2022.2

  potent analogue in the series with fifteen folds more active than standard acarbose. Structure activity relationship (SAR) studies suggested that α-glucosidase activities of triazinoindole bearing thiadiazole are primarily dependent upon on number and position of different substitutions present on phenyl parts. Molecular docking study were conducted of the optimized compounds (i.e., compound 4, 6, and

  已通过不同的光谱技术如1 H、13 C-NMR 和 HREI-MS合成并表征了带有噻二唑衍生物 ( 1-25 ) 的三嗪吲哚。本研究的目的是通过抑制α-葡萄糖苷酶来研究合成的三嗪吲哚噻二唑衍生物的抗糖尿病活性。与标准药物阿卡波糖（IC 50 = 38.45 ± 0.80 µM）相比，所有合成的类似物均显示出对α-葡萄糖苷酶的显着抑制作用，IC 50值范围为 2.5 ± 0.10 至 38.10 ± 0.10 µ M。模拟4 (IC 50 = 2.5 ± 0.10µ M) 被确定为该系列中最有效的类似物，其活性是标准阿卡波糖的 15 倍。结构活性关系（SAR）研究表明，带有噻二唑的三嗪吲哚的α-葡萄糖苷酶活性主要取决于苯基部分上不同取代的数量和位置。对优化后的化合物（即化合物 4、6 和 3 等，使用 MOE 默认参数）进行分子对接研究，结果表明化合物 4、6 和 3 与靶蛋白有许多关键的相
• Human androgen receptor DNA-binding domain (DBD) compounds as therapeutics and methods for their use
  申请人：The University of British Columbia

  公开号：US10011573B2

  公开（公告）日：2018-07-03

  A compound having the structure of Formula I, wherein A is a substituted or unsubstituted aryl or heteroaryl group, D is a substituted or unsubstituted 5- or 6-membered heteroaryl or heterocyclyl group and E is a substituted or unsubstituted aryl, heteroaryl, cycloalkyl or heterocyclyl group. The compounds are used for the treatment of androgen modulated indications including cancer (prostate, breast, ovarian, endometrial or bladder cancer), hair loss, acne, hirsutism, ovarian cysts, polycystic ovary disease, precocious puberty and age related macular degeneration. The use of the compounds for the manufacture of a medicament for modulating AR activity, a method of treatment using such compounds and a pharmaceutical composition and a commercial package comprising said compounds are also described.

  具有式 I 结构的化合物，其中 A 是取代或未取代的芳基或杂芳基，D 是取代或未取代的 5 或 6 元杂芳基或杂环基，E 是取代或未取代的芳基、杂芳基、环烷基或杂环基。这些化合物可用于治疗雄激素调节适应症，包括癌症（前列腺癌、乳腺癌、卵巢癌、子宫内膜癌或膀胱癌）、脱发、痤疮、多毛症、卵巢囊肿、多囊卵巢病、性早熟和老年性黄斑变性。此外，还描述了这些化合物在制造调节 AR 活性的药物中的用途、使用这些化合物的治疗方法以及包含上述化合物的药物组合物和商业包装。
• Non-toxic corrosion-protection pigments based on manganese
  申请人：——

  公开号：US20040011252A1

  公开（公告）日：2004-01-22

  Corrosion-inhibiting pigments based on manganese are described that contain a trivalent or tetravalent manganese/valence stabilizer complex. An inorganic or organic material is used to stabilize the trivalent or tetravalent manganese ion to form a compound that is sparingly soluble, exhibits low solubility, or is insoluble in water, depending upon the intended usage. Specific stabilizers are chosen to control the release rate of trivalent or tetravalent manganese during exposure to water and to tailor the compatibility of the powder when used as a pigment in a chosen binder system. Stabilizers may also modify the processing and handling characteristics of the formed powders. Manganese/valence stabilizer combinations are chosen based on the well-founded principles of manganese coordination chemistry. Many manganese-valence stabilizer combinations are presented that can equal the performance of conventional hexavalent chromium or tetravalent lead systems. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.

  以锰为基础的缓蚀颜料含有三价或四价锰/价稳定剂复合物。一种无机或有机材料可用于稳定三价或四价锰离子，从而形成一种可少量溶解、溶解度低或不溶于水的化合物，具体取决于预期用途。选择特定的稳定剂是为了控制三价锰或四价锰在遇水时的释放率，并调整粉末在所选粘合剂体系中用作颜料时的相容性。稳定剂还可以改变成型粉末的加工和处理特性。锰/价稳定剂组合的选择是基于锰配位化学的基本原理。文中介绍了许多锰价稳定剂组合，其性能与传统的六价铬或四价铅体系相当。需要强调的是，提供本摘要是为了符合要求提供摘要的规则，以便检索者或其他读者快速确定技术公开的主题。提交本摘要的前提是，本摘要不用于解释或限制权利要求的范围或含义。
• Non-toxic corrosion-protection pigments based on rare earth elements
  申请人：——

  公开号：US20040104377A1

  公开（公告）日：2004-06-03

  A corrosion-inhibiting pigment comprising a rare earth element and a valence stabilizer combinded to form a rare earth/valence stabilizer complex. The rare earth element is selected from cerium, terbium, praseodymium, or a combination thereof, and at least one rare earth element is in the tetravalent oxidation state. An inorganic or organic material is used to stabilize the tetravalent rare earth ion to form a compound that is sparingly soluble in water. Specific stabilizers are chosen to control the release rate of tetravalent cerium, terbium, or praseodymium during exposure to water and to tailor the compatibility of the powder when used as a pigment in a chosen binder system. Stabilizers may also modify the processing and handling characteristics of the formed powders. Many rare earth-valence stabilizer combinations are presented that can equal the performance of conventional hexavalent chromium systems.

  一种缓蚀颜料，由稀土元素和价态稳定剂结合形成稀土/价态稳定剂复合物。稀土元素选自铈、铽、镨或它们的组合，至少有一种稀土元素处于四价氧化态。使用无机或有机材料来稳定四价稀土离子，以形成稀溶于水的化合物。选择特定的稳定剂是为了控制四价铈、铽或镨在遇水时的释放率，并调整粉末在所选粘合剂体系中用作颜料时的相容性。稳定剂还可以改变成型粉末的加工和处理特性。本文介绍了许多稀土-价稳定剂组合，其性能可与传统的六价铬体系媲美。
• A novel chemosensor based on Fe(III)-complexation for selective recognition and rapid detection of fluoride anions in aqueous media
  作者：Wei Lu、Han Jiang、Fangyu Hu、Liming Jiang、Zhiquan Shen

  DOI：10.1016/j.tet.2011.08.035

  日期：2011.10

  A novel fluorogenic receptor 1 was prepared by the reaction of thiosemicarbazide with 1-naphthaldehyde. Based on in situ-formed 1-Fe(III) complexes having the specific binding affinity for F- anions, this sensory system allows rapid recognition and quantitative detection of fluoride in neutral aqueous media in an 'off-on' fashion. The fluoride measurement method not only exhibits a low detection limit but also has strong anti-interference ability to common coexisting ions, as evidenced by competitive experiments. (C) 2011 Elsevier Ltd. All rights reserved.